This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The Administrative Core is directed by the Principal Investigator (PI) and includes two office staff members (one 0.9 FTE and one 0.5 FTE) who oversee all administrative activities including accounting, travel arrangements, meetings, Steering and External Advisory Committee (EAC) activities, summer student programs, budgets, the INBRE website, and other activities. During the 03 year, all of these activities were carried out according to plan. The EAC meet once during the 06 year and will meet again near the end of the 06 year in April 2007. Investigators of the ten INBRE Junior Investigator projects have presented, or will present to both the steering committee and the EAC at least once during the 06 year. The PI has carried out regular visits to the laboratories of each of the 10 INBRE project scientists. A report has been commissioned for each year of the INBRE by the American Association for the Advancement of Science (AAAS) Research Competitiveness Program to provide an evaluation of the progress of the INBRE and the implementation of the INBRE plan at INBRE undergraduate institutions. The AAAS site visit was carried out February 7-9 the 06 year.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR016478-08
Application #
7725092
Study Section
Special Emphasis Panel (ZRR1-RI-7 (02))
Project Start
2008-05-01
Project End
2009-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
8
Fiscal Year
2008
Total Cost
$704,484
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Hu, Zihua; Jiang, Kaiyu; Frank, Mark Barton et al. (2018) Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis. Sci Rep 8:7805
Wetherill, Marianna S; Williams, Mary B; Gray, Karen A (2017) SNAP-Based Incentive Programs at Farmers' Markets: Adaptation Considerations for Temporary Assistance for Needy Families (TANF) Recipients. J Nutr Educ Behav 49:743-751.e1
Hannafon, Bethany N; Trigoso, Yvonne D; Calloway, Cameron L et al. (2016) Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res 18:90
Wilson, Kevin R; Cannon-Smith, Desiray J; Burke, Benjamin P et al. (2016) Synthesis and structural studies of two pyridine-armed reinforced cyclen chelators and their transition metal complexes. Polyhedron 114:118-127
Trigoso, Yvonne D; Evans, Russell C; Karsten, William E et al. (2016) Cloning, Expression, and Purification of Histidine-Tagged Escherichia coli Dihydrodipicolinate Reductase. PLoS One 11:e0146525
Khandaker, Morshed; Riahinezhad, Shahram; Sultana, Fariha et al. (2016) Peen treatment on a titanium implant: effect of roughness, osteoblast cell functions, and bonding with bone cement. Int J Nanomedicine 11:585-94
Hu, Zihua; Jiang, Kaiyu; Frank, Mark Barton et al. (2016) Complexity and Specificity of the Neutrophil Transcriptomes in Juvenile Idiopathic Arthritis. Sci Rep 6:27453
Seong, Jaehoon; Jeong, Woowon; Smith, Nataliya et al. (2015) Hemodynamic effects of long-term morphological changes in the human carotid sinus. J Biomech 48:956-62
Day, Michael W; Jackson, Lydgia A; Akins, Darrin R et al. (2015) Whole-Genome Sequences of the Archetypal K1 Escherichia coli Neonatal Isolate RS218 and Contemporary Neonatal Bacteremia Clinical Isolates SCB11, SCB12, and SCB15. Genome Announc 3:
Hannafon, Bethany N; Carpenter, Karla J; Berry, William L et al. (2015) Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer 14:133

Showing the most recent 10 out of 165 publications